Since
winter
2019,
SARS-CoV-2
has
emerged,
spread,
and
evolved
all
around
the
globe.
We
explore
4
y
of
evolutionary
epidemiology
this
virus,
ranging
from
applied
public
health
challenges
to
more
conceptual
biology
perspectives.
Through
review,
we
first
present
spread
lethality
infections
it
causes,
starting
its
emergence
in
Wuhan
(China)
initial
epidemics
world,
compare
virus
other
betacoronaviruses,
focus
on
airborne
transmission,
containment
strategies
("zero-COVID"
vs.
"herd
immunity"),
explain
phylogeographical
tracking,
underline
importance
natural
selection
epidemics,
mention
within-host
population
dynamics.
Finally,
discuss
how
pandemic
transformed
(or
should
transform)
surveillance
prevention
viral
respiratory
identify
perspectives
for
research
COVID-19.
PLoS Pathogens,
Год журнала:
2023,
Номер
19(12), С. e1011868 - e1011868
Опубликована: Дек. 20, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
XBB
lineages
have
achieved
dominance
worldwide
and
keep
on
evolving.
Convergent
evolution
of
the
receptor-binding
domain
(RBD)
L455F
F456L
is
observed,
resulting
in
variants
with
substantial
growth
advantages,
such
as
EG.5,
FL.1.5.1,
XBB.1.5.70,
HK.3.
Here,
we
show
that
neutralizing
antibody
(NAb)
evasion
drives
convergent
F456L,
while
epistatic
shift
caused
by
enables
subsequent
convergence
through
ACE2
binding
enhancement
further
immune
evasion.
evade
RBD-targeting
Class
1
public
NAbs,
reducing
neutralization
efficacy
breakthrough
infection
(BTI)
reinfection
convalescent
plasma.
Importantly,
single
substitution
significantly
dampens
receptor
binding;
however,
combination
forms
an
adjacent
residue
flipping,
which
leads
to
enhanced
NAbs
resistance
affinity.
The
perturbed
mode
exceptional
NAb
evasion,
revealed
structural
analyses.
Our
results
indicate
flexibility
contributed
epistasis
cannot
be
underestimated,
potential
SARS-CoV-2
RBD
remains
high.
Protein & Cell,
Год журнала:
2024,
Номер
15(6), С. 403 - 418
Опубликована: Март 4, 2024
Intensive
selection
pressure
constrains
the
evolutionary
trajectory
of
SARS-CoV-2
genomes
and
results
in
various
novel
variants
with
distinct
mutation
profiles.
Point
mutations,
particularly
those
within
receptor
binding
domain
(RBD)
spike
(S)
protein,
lead
to
functional
alteration
both
engagement
monoclonal
antibody
(mAb)
recognition.
Here,
we
review
data
RBD
point
mutations
possessed
by
major
discuss
their
individual
effects
on
ACE2
affinity
immune
evasion.
Many
single
amino
acid
substitutions
epitopes
crucial
for
evasion
capacity
may
conversely
weaken
affinity.
However,
this
weakened
effect
could
be
largely
compensated
specific
epistatic
such
as
N501Y,
thus
maintaining
overall
protein
all
variants.
The
predominant
direction
evolution
lies
neither
promoting
nor
evading
mAb
neutralization
but
a
delicate
balance
between
these
two
dimensions.
Together,
interprets
how
efficiently
resist
meanwhile
is
maintained,
emphasizing
significance
comprehensive
assessment
mutations.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 22, 2024
Abstract
The
continuous
evolution
of
SARS-CoV-2,
particularly
the
emergence
BA.2.86/JN.1
lineage
replacing
XBB
lineages,
necessitates
re-evaluation
current
vaccine
compositions.
Here,
we
provide
a
comprehensive
analysis
humoral
immune
response
to
and
JN.1
human
exposures,
emphasizing
need
for
JN.1-lineage-based
boosters.
We
demonstrate
antigenic
distinctiveness
lineages
in
SARS-CoV-2-naive
individuals
but
not
those
with
prior
vaccinations
or
infections,
infection
elicits
superior
plasma
neutralization
titers
against
its
subvariants.
highlight
strong
evasion
receptor
binding
capability
KP.3,
supporting
foreseeable
prevalence.
Extensive
BCR
repertoire,
isolating
∼2000
RBD-specific
monoclonal
antibodies
(mAbs)
their
targeting
epitopes
characterized
by
deep
mutational
scanning
(DMS),
underscores
systematic
superiority
JN.1-elicited
memory
B
cells
(MBCs).
Notably,
Class
1
IGHV3-53/3-66-derived
neutralizing
(NAbs)
contribute
majorly
within
wildtype
(WT)-reactive
NAbs
JN.1.
However,
KP.2
KP.3
evade
substantial
subset
them,
even
induced
JN.1,
advocating
booster
updates
optimized
enrichment.
JN.1-induced
Omicron-specific
also
high
potency
across
all
Omicron
lineages.
Escape
hotspots
these
have
mainly
been
mutated
RBD,
resulting
higher
barrier
escape,
considering
probable
recovery
previously
escaped
NAbs.
Additionally,
prevalence
broadly
reactive
IGHV3-53/3-66-
encoding
MBCs,
competing
suggests
inhibitory
role
on
de
novo
activation
naive
cells,
potentially
explaining
heavy
imprinting
mRNA-vaccinated
individuals.
These
findings
delineate
evolving
antibody
shift
from
importance
developing
lineage,
especially
KP.3-based
boosters,
enhance
immunity
future
SARS-CoV-2
variants.
Cell Reports,
Год журнала:
2023,
Номер
42(12), С. 113444 - 113444
Опубликована: Ноя. 18, 2023
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
variant
of
concern,
first
identified
in
November
2021,
rapidly
spread
worldwide
and
diversified
into
several
subvariants.
spike
(S)
protein
accumulated
an
unprecedented
number
sequence
changes
relative
to
previous
variants.
In
this
review,
we
discuss
how
S
structural
features
modulate
host
cell
receptor
binding,
virus
entry,
immune
evasion
highlight
these
differentiate
from
We
also
examine
key
properties
track
across
the
still-evolving
subvariants
importance
continuing
surveillance
evolution
over
time.
Deep
mutational
scanning
experiments
aid
in
the
surveillance
and
forecasting
of
viral
evolution
by
providing
prospective
measurements
effects
on
traits,
but
epistatic
shifts
impacts
mutations
can
hinder
when
were
made
outdated
strain
backgrounds.
Here,
we
report
impact
all
single
amino
acid
ACE2-binding
affinity
protein
folding
expression
SARS-CoV-2
Omicron
BA.2.86
spike
receptor-binding
domain.
As
with
other
variants,
find
a
plastic
evolvable
basis
for
receptor
binding,
many
at
ACE2
interface
maintaining
or
even
improving
affinity.
Despite
its
large
genetic
divergence,
have
not
diverged
greatly
from
those
measured
BA.2
ancestor.
However,
do
identify
strong
positive
epistasis
among
subsequent
that
accrued
descendants.
Specifically,
Q493E
mutation
decreased
previous
backgrounds
is
reversed
sign
to
enhance
human
coupled
L455S
F456L
currently
emerging
KP.3
variant.
Our
results
point
modest
degree
drift
during
recent
highlight
how
these
small
important
consequences
emergence
new
variants.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 18, 2024
Abstract
Monoclonal
antibodies
(mAbs)
targeting
the
SARS-CoV-2
receptor-binding
domain
(RBD)
showed
high
efficacy
in
prevention
and
treatment
of
COVID-19.
However,
rapid
evolution
has
rendered
all
clinically
authorized
mAbs
ineffective
continues
to
stymie
development
next-generation
mAbs.
Consequently,
ability
identify
broadly
neutralizing
(bnAbs)
that
neutralize
both
current
future
variants
is
critical
for
successful
antibody
therapeutic
development,
especially
newly
emerged
viruses
when
no
knowledge
about
immune
evasive
available.
Here,
we
have
developed
a
strategy
specifically
select
potent
bnAbs
with
activity
against
existing
prospective
based
on
accurate
viral
prediction
informed
by
deep
mutational
scanning
(DMS).
By
adopting
this
methodology,
increased
probability
identifying
XBB.1.5-effective
from
∼1%
40%
if
were
at
early
stage
pandemic,
as
revealed
retrospective
analysis
>1,000
wildtype
(WT)-elicited
From
collection,
identified
bnAb,
designated
BD55-1205,
exhibited
exceptional
historical,
contemporary,
predicted
variants.
Structural
analyses
extensive
polar
interactions
between
BD55-1205
XBB.1.5
motif
(RBM),
backbone
atoms,
explaining
its
unusually
broad
reactivity.
Importantly,
mRNA-based
delivery
IgG
human
FcRn-expressing
transgenic
mice
resulted
serum
titers
selected
XBB
BA.2.86
subvariants.
Together,
via
prediction,
coupled
speed
flexibility
mRNA
technology,
provides
generalized
framework
antibody-based
countermeasures
potentially
other
highly
variable
pathogens
pandemic
potential.
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
evolution
has
resulted
in
viral
escape
from
clinically
authorized
monoclonal
antibodies
(mAbs),
creating
a
need
for
mAbs
that
are
resilient
to
epitope
diversification.
Broadly
neutralizing
sufficiently
potent
clinical
development
and
retain
activity
despite
remain
elusive.
We
identified
human
mAb,
designated
VIR-7229,
which
targets
the
receptor-binding
motif
(RBM)
with
unprecedented
cross-reactivity
all
sarbecovirus
clades,
including
non-ACE2-utilizing
bat
sarbecoviruses,
while
potently
SARS-CoV-2
variants
since
2019,
recent
EG.5,
BA.2.86,
JN.1.
VIR-7229
tolerates
extraordinary
variability,
partly
attributed
its
high
binding
affinity,
receptor
molecular
mimicry,
interactions
RBM
backbone
atoms.
Consequently,
features
barrier
selection
of
mutants,
rare
associated
reduced
fitness,
underscoring
potential
be
future
evolution.
is
strong
candidate
become
next-generation
medicine.
Proceedings of the National Academy of Sciences,
Год журнала:
2025,
Номер
122(2)
Опубликована: Янв. 8, 2025
The
course
of
evolution
is
strongly
shaped
by
interaction
between
mutations.
Such
epistasis
can
yield
rugged
sequence–function
maps
and
constrain
the
availability
adaptive
paths.
While
theoretical
intuition
often
built
on
global
statistics
large,
homogeneous
model
landscapes,
mutagenesis
measurements
necessarily
probe
a
limited
neighborhood
reference
genotype.
It
unclear
to
what
extent
local
topography
real
epistatic
landscape
represents
its
shape.
Here,
we
demonstrate
that
landscapes
be
heterogeneously
this
heterogeneity
may
render
biomolecules
more
evolvable.
By
characterizing
multipeaked
fitness
SARS-CoV-2
antibody
mutant
library,
show
heterogeneous
ruggedness
arises
from
sparse
hotspots,
whose
mutation
impacts
effect
numerous
sequence
sites.
Surprisingly,
mutating
an
hotspot
enhance,
rather
than
reduce,
accessibility
fittest
genotype,
while
increasing
overall
ruggedness.
Further,
migratory
constraints
in
space
alleviate
mutational
space,
which
not
only
diversify
direct
paths
taken
but
also
turn
road-blocking
peak
into
stepping
stone
leading
toward
optimum.
Our
results
suggest
hierarchy
hotspots
organize
such
way
path-orienting
confers
smoothness.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Ноя. 14, 2023
SARS-CoV-2
variants
acquire
mutations
in
spike
that
promote
immune
evasion
and
impact
other
properties
contribute
to
viral
fitness
such
as
ACE2
receptor
binding
cell
entry.
Knowledge
of
how
affect
these
phenotypes
can
provide
insight
into
the
current
potential
future
evolution
virus.
Here
we
use
pseudovirus
deep
mutational
scanning
measure
>9,000
across
full
XBB.1.5
BA.2
spikes
binding,
entry,
or
escape
from
human
sera.
We
find
outside
receptor-binding
domain
(RBD)
have
meaningfully
impacted
during
evolution.
also
neutralization
by
serum
individuals
who
recently
had
infections.
The
strongest
are
RBD
at
sites
357,
420,
440,
456,
473-however,
antigenic
impacts
vary
individuals.
identify
strong
RBD;
however
many
them
decrease
suggesting
they
act
modulating
conformation.
Notably,
growth
rates
clades
be
explained
substantial
part
measured
effects
on
phenotypes,
our
data
could
enable
better
prediction